ANNA WELLS-SHARP: Open Payments
NPI 1790019602 · BLUFFTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$384 in 19 payments from 9 companies in 2025. Trend: 2023 $210 · 2024 $284 · 2025 $384
Food & beverage: $384
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $134 |
| Amgen Inc. | 3 | $55 |
| Lilly USA, LLC | 2 | $36 |
| Exact Sciences Corporation | 2 | $36 |
| PFIZER INC. | 1 | $32 |
| Corcept Therapeutics | 1 | $30 |
| Alnylam Pharmaceuticals Inc. | 1 | $25 |
| Novo Nordisk Inc | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: AIRSUPRA, BREZTRI, OTEZLA, MOUNJARO, PREVNAR 20, Korlym, ONPATTRO, Wegovy.
Industry payments across SC — which companies pay providers there.
